By 10 weeks of age, β-cell mass is reduced and IUGR rats have developed mild-fasting hyperglycemia and exhibit diminished glucose- and leucine-stimulated insulin secretion [3,6,7,8]. The gene discussed is INS; the disease is fetal growth restriction.